Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from Onco-Innovations Ltd. ( (TSE:ONCO) ).
Onco-Innovations Limited, through its subsidiary Inka Health Corp., recently chaired a pivotal roundtable session as part of Colorectal Cancer Canada’s Catalysts series, focusing on precision oncology. The session, which gathered leaders from various sectors, emphasized the need for coordinated innovation and data-driven approaches to make precision oncology equitable and routine worldwide. The outcomes of this session are expected to guide future publications and the formation of working groups to advance high-impact research and public-private partnerships.
More about Onco-Innovations Ltd.
Onco-Innovations is a Canadian-based company dedicated to cancer research and treatment, specializing in oncology. The company focuses on pioneering research and innovative solutions for the prevention and treatment of cancer, and has secured an exclusive worldwide license to patented technology targeting solid tumors.
Average Trading Volume: 39,032
Technical Sentiment Signal: Strong Sell
Current Market Cap: C$79.79M
Find detailed analytics on ONCO stock on TipRanks’ Stock Analysis page.